Corinne Johnson
Stock Analyst at Goldman Sachs
(2.05)
# 2,853
Out of 4,670 analysts
7
Total ratings
50%
Success rate
6.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Initiates: Buy | $59 | $43.25 | +36.42% | 1 | Sep 24, 2024 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $28 → $38 | $27.45 | +38.43% | 2 | Sep 10, 2024 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $33.47 | +49.39% | 3 | May 14, 2024 | |
| IMVT Immunovant | Initiates: Buy | $50 | $26.87 | +86.08% | 1 | Mar 13, 2024 |
Avidity Biosciences
Sep 24, 2024
Initiates: Buy
Price Target: $59
Current: $43.25
Upside: +36.42%
ArriVent BioPharma
Sep 10, 2024
Maintains: Buy
Price Target: $28 → $38
Current: $27.45
Upside: +38.43%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $33.47
Upside: +49.39%
Immunovant
Mar 13, 2024
Initiates: Buy
Price Target: $50
Current: $26.87
Upside: +86.08%